Tag: Liver Disease: Misc.
Bariatric Surgery Effective, Cost-Effective in Obese With NASH
For overweight patients, surgery is effective, but cost-effectiveness limited to those with F3 fibrosis
Optimal MELD Threshold for HCV Tx Pre-Liver Transplant 23 to 27
Treating HCV before liver transplant increased life expectancy if MELD was ≤27
Herbal, Dietary Supplements Cause One-Fifth of Hepatotoxicity
Major implicated agents include anabolic steroids, green tea, multi-ingredient nutritional supplements
Liver Stiffness Linked to Hepatic Events, Death in Hepatitis B
Metabolic syndrome ups risk of cardiovascular events, not hepatic events or death in chronic hep B
Burden of Cirrhosis, Acute-on-Chronic Liver Failure Increasing
From 2001 to 2011, number of hospitalizations for cirrhosis nearly doubled; prevalence of ACLF up
NASH ID’d by Mass Spectrometry-Based Profiling, Clinical Variables
MS-based profiling combined with clinical variables accurately identifies nonalcoholic steatohepatitis
Physical Activity Reduces Intrahepatic Lipid Content
Reductions also seen in alanine aminotransferase and aspartate aminotransferase in NAFLD
Early TIPS Beneficial in Acute Esophageal Variceal Bleeding
In-hospital reductions in rebleeding, mortality with transjugular intrahepatic portosystemic shunt
Changes in Blood Microbiota in Obese With Liver Fibrosis
Among obese patients, 16S rDNA concentration significantly higher for those with liver fibrosis
High Glycemic Index Diet Raises Hepatic Fat, Glycogen Stores
One-week high GI diet increases hepatic fat and glycogen stores compared with low GI diet
